www.marketwatch.com
Summarize this content to 100 words: The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.
Read More
Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026
By mychabi2013
